Lipids

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Clinical Insights

Expert Q&A
brian a bergmark md
Expert Q&A
Targeting APOC3: A Potential New Tool for Managing Hypertriglyceridemia
02/05/2026
Brian A. Bergmark, MD
In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...
02/05/2026
Video
samar
Video
High Volume of Healthy Vascular Fat During Menopause Associated With Better Brain Health Later in Life
04/14/2024
Samar R. El Khoudary, PhD, MPH, BPharm, FAHA
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
Lipids
Maura J. Jones, PharmD, BCPS
Lipids
Lipid Management for Patients With Diabetes
03/15/2023
In this podcast, Maura Jones, PharmD, BCPS, discusses clinical practice guidelines and various medication regimens for managing cardiovascular disease risks in patients with diabetes. This was a topic she...
03/15/2023
Cardiovascular Diseases
Cardiovascular Diseases
Treatment of Dyslipidemia
07/11/2022
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
07/11/2022
Lipid & Metabolic
Lipid & Metabolic
Paul Jellinger, MD, MACE, on the Role of CAC Score
12/31/2020
In part 5 of our series on lipid management, Paul Jellinger, MD, MACE, highlights the importance of coronary artery calcium score as a risk factor for ASCVD and its role in diagnosis and treatment of...
12/31/2020
Multiple Sclerosis
Multiple Sclerosis
Murali Ramanathan, PhD, on How Lipid Management Affects MS Outcomes
04/21/2020
He discusses his latest research on how managing lipid levels with the Wahls diet and other integrative interventions affects fatigue related to multiple sclerosis.
04/21/2020
Cardiovascular Diseases
Cardiovascular Diseases
Michael Bloch, MD, on Hypercholesterolemia: A Focus on PCSK9 Inhibitors
11/19/2019
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
11/19/2019
Cardiometabolic Risk
Cardiometabolic Risk
James Matera, MD, on Managing Hyperkalemia With Novel Potassium Binders to Achieve Optimal Outcomes
11/18/2019
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
11/18/2019
Lipid & Metabolic
Lipid & Metabolic
Laurence Sperling, MD, on the 2018 Cholesterol Guidelines
08/14/2019
In this podcast, Laurence Sperling, MD, from Emory University School of Medicine, explains the newest ACC/AHA cholesterol guidelines, the top 10 take-home messages for cardiologists, and the lessons learned...
08/14/2019
Lipid & Metabolic
Lipid & Metabolic
Paul Jellinger, MD, MACE, on Testing for ASCVD
04/24/2019
In part 4 of our series on lipid management, Paul Jellinger, MD, explains the answer to the quiz question from part 3 of the series and talks about the role of the MESA Study in the treatment of...
04/24/2019